Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
March 28, 2024 07:55 ET
|
Aeterna Zentaris Inc
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce...
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
March 27, 2024 08:05 ET
|
Aeterna Zentaris Inc
- Company confirms successful completion of enrollment in the pivotal DETECT Phase 3 trial - Company ended the year with $34.0 million in cash, expected to fund operations through 2024 and into...
Aetherium Acquisition Corp Announces Postponement of Adjourned Special Meeting of Stockholders
March 19, 2024 09:00 ET
|
Aetherium Acquisition Corp.
~ Stockholders of Record as of February 9, 2024, are Eligible to Vote at Meeting ~ New York, March 19, 2024 (GLOBE NEWSWIRE) -- Aetherium Acquisition Corp (“Aetherium”) (NASDAQ:GMFI), a special...
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
March 12, 2024 14:10 ET
|
Aeterna Zentaris Inc
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”) are pleased to announce...
Generic Drugs market is projected to grow at a CAGR of 5.3% by 2034: Visiongain
March 07, 2024 12:02 ET
|
Visiongain Reports Ltd
Visiongain has published a new report Generic Drugs Market Report 2024-2034: Forecasts by Type (Simple Generics, Specialty Generics, Biosimilars), by Prescription Type (Prescription Generics,...
Aetherium Acquisition Corp Announces Postponement of Special Meeting of Stockholders
March 04, 2024 17:42 ET
|
Aetherium Acquisition Corp.
~ Stockholders of Record as of February 9, 2024, are Eligible to Vote at Meeting ~ New York, March 04, 2024 (GLOBE NEWSWIRE) -- Aetherium Acquisition Corp (“Aetherium”) (NASDAQ:GMFI), a special...
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
February 26, 2024 07:30 ET
|
Aeterna Zentaris Inc
ISS states in its Aeterna Zentaris FOR recommendation that “on balance, the deal has strong strategic merit, third party solicitation was unable to generate any other actionable proposals, and...
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
February 15, 2024 17:50 ET
|
Aeterna Zentaris Inc
Aeterna Zentaris Board recommends shareholders vote FOR all resolutions, to create a diversified biopharmaceutical company with a compelling value propositionMore information and materials available...
Aether Fuels and GTI Energy Announce Partnership and Exclusive Licensing Deal to Accelerate Commercialization of Sustainable Fuels for Aviation and Ocean Shipping
February 05, 2024 09:00 ET
|
Aether Fuels
Aether Fuels and GTI Energy collaborate to commercialize a scalable solution to produce sustainable fuels from abundant low-value waste streams.
Aether Fuels Raises US$8.5 Million to Develop Sustainable Fuels for Aviation and Ocean Shipping
December 14, 2023 12:00 ET
|
Aether Fuels
Aether Fuels secures US$8.5 million from JetBlue Ventures, TechEnergy Ventures, Doral Energy Tech Ventures, Foothill Ventures & Xora Innovation.